Public Citizen Urges FDA To Penalize Drug Makers Over Diabetes Ads,…
Consumer advocacy group Public Citizen is calling on the Food and Drug Administration (FDA) to “stop the apparently violative…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Laboratory Referral Arrangements Under the Gun
Referral arrangements between laboratories and physicians have received a lot of scrutiny lately. Last week, it was…
CBI’s Sixth Annual Transparency Reporting West, April 21-22 in San…
Learn new strategies to streamline Open Payments reporting and leverage data analytics to improve risk management and…
Judge Dismisses Off-Label and Kickback Allegations Against Bristol-Myers…
District Court Judge William Bertelsman recently dismissed False Claims Act (FCA) allegations against Bristol-Myers…
CMS: Open Payments Data Submission and Attestation Period Open until…
The Centers for Medicare and Medicaid Services (CMS) has just announced that the Open Payments data submission period will…
Open Payments Submissions Due Today, March 31; Vermont Reports Due…
Manufacturers must submit their Open Payments reports to the Centers for Medicare and Medicaid Services (CMS) today, March 31.…
New Zealand Transparency Advocates Call For Sunshine Act
A group of transparency advocates in New Zealand has been writing various articles on the value of “more Sunshine” for a…
BioChemics, Inc. Pays the SEC $17.9 Million For Allegedly Misrepresenting…
BioChemics, Inc., a Massachusetts-based biopharmaceutical company was ordered Wednesday to pay a total of almost $18…
West Virginia Prescription Drug Advertising Expense Reporting Rule REPEALED
On March 24th, West Virginia’s Governor, Earl Ray Tomblin, approved SB 267, which repeals the state’s Prescription Drug…
SGR Repeal: Bipartisan Leaders Announce Repeal To Be Considered Before…
This time last year, we analyzed 2014’s sustainable growth rate (SGR) fix. Although a bipartisan group of lawmakers announced they…